EDN1 and COVID-19: In COVID-19, circulating markers of thrombosis and endothelial injury (D-dimer, angiopoietin-2, endothelin-1 and von Willebrand Factor A2) increase in a stepwise fashion with disease severity (along the World Health Organization ordinal severity scale) with equivalent concentrations in patients who require IMV and survive compared with patients who die [18].